MedKoo Cat#: 525867 | Name: BCI-215

Description:

WARNING: This product is for research use only, not for human or veterinary use.

BCI-215 was discontinued.

Chemical Structure

BCI-215
BCI-215
CAS#1245792-67-9

Theoretical Analysis

MedKoo Cat#: 525867

Name: BCI-215

CAS#: 1245792-67-9

Chemical Formula: C22H22BrNO

Exact Mass: 395.0885

Molecular Weight: 396.33

Elemental Analysis: C, 66.67; H, 5.60; Br, 20.16; N, 3.53; O, 4.04

Price and Availability

This product was removed for the commercial reasons.
Related CAS #
No Data
Synonym
BCI-215; BCI 215; BCI215;
IUPAC/Chemical Name
(E)-2-Benzylidene-5-bromo-3-cyclohexylamino-indan-1-one
InChi Key
JGWQWVVSCQBAFC-DEDYPNTBSA-N
InChi Code
InChI=1S/C22H22BrNO/c23-16-11-12-18-19(14-16)21(24-17-9-5-2-6-10-17)20(22(18)25)13-15-7-3-1-4-8-15/h1,3-4,7-8,11-14,17,21,24H,2,5-6,9-10H2/b20-13+
SMILES Code
O=C1/C(C(NC2CCCCC2)C3=C1C=CC(Br)=C3)=C/C4=CC=CC=C4
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 396.33 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Kaltenmeier CT, Vollmer LL, Vernetti LA, Caprio L, Davis K, Korotchenko VN, Day BW, Tsang M, Hulkower KI, Lotze MT, Vogt A. A Tumor Cell-Selective Inhibitor of Mitogen-Activated Protein Kinase Phosphatases Sensitizes Breast Cancer Cells to Lymphokine-Activated Killer Cell Activity. J Pharmacol Exp Ther. 2017 Apr;361(1):39-50. doi: 10.1124/jpet.116.239756. Epub 2017 Feb 2. PubMed PMID: 28154014; PubMed Central PMCID: PMC5363763.